LEXX - lexariabioscience.com Qarzning balans kapitallashuviga nisbati

Lexaria Bioscience Corp. (LEXX) grafik logotipi

CDMO litsenziyalash modeli Lexaria Bioscience uchun ishlab chiqarish risklarini minimallashtiradi. Kompaniyaning joriy qarzning kapitalizatsiyaga nisbati moliyaviy barqarorlikni aniq namoyish etadi, bunda 0.02 qiymati metrika darajasini ifodalaydi. DehydraTECH orqali parhez qo'shimchalari ishlab chiqaruvchilari bilan sinergiya molekulyar bio-mavjudlikni tezlashtiradi, biznes muvaffaqiyati esa sog'liqni saqlash gigantlari tomonidan gipertoniya va diabetni davolash tizimlarining qabul qilinishiga bog'liq.

LEXX (Lexaria Bioscience Corp.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 26.10.2026gacha

lexariabioscience.com (LEXX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Lexaria Bioscience Corp.|LEXX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Lexaria Bioscience Corp.|LEXX - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Lexaria Bioscience|LEXX - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati lexariabioscience.com|LEXX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Lexaria Bioscience|LEXX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Lexaria Bioscience Corp.|LEXX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Lexaria Bioscience Corp.
Kompaniyaning barcha koʻrsatkichlari tahlili:LEXX Lexaria
Lexaria Bioscience Corp. asosiy tovari

Ushbu koeffitsient umumiy majburiyatlarning kapitalning bozor qiymatiga nisbatiga bo'linishi orqali hisoblanadi. Mazkur metrika biznesning qarz mablag'lariga bog'liqligini va moliyaviy zarbalarga nisbatan barqarorligini belgilaydi. DehydraTECH loyihalariga investitsiyalar va yuqori malakali olimlar jamoasiga ega bo'lgan Lexaria Bioscience (LEXX) uchun leveraj balansi tadqiqot va ishlanmalar (R&D) dinamikasini saqlab qolish uchun juda muhimdir. Qarzning bozor kapitalizatsiyasiga nisbatini tahlil qilish orqali investor kapital qiymatini va kompaniyaning xavfsizlik zaxirasini baholaydi.

Lexaria Bioscience raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|Qarzning balans kapitallashuviga nisbati China SXT Pharmaceuticals, Inc. SXTC|Qarzning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals, Inc. EPRX|BHST (BioHarvest) - Balans kapitallashuviga qarzlar|Invizyne (EXOZ) - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati oramed.com|Entera Bio (ENTX) - Qarzning balans qiymatiga nisbati|HYFT (MindWalk Holdings Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ABVC|Cumberland Pharma (CPIX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Quantum BioPharma Corp (QNTM)|Balans kapitallashuviga qarzlar FGEN|Sof aktivlarga qarzlar telomirpharma.com TELO|Rani Therapeutics Inc - Balans kapitallashuviga qarzlar|Synergy CHC Corp (SNYR) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati rallybio.com RLYB|Pulmatrix Corporation (PULM) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Pheton Holdings Limited|Qarzning balans kapitallashuviga nisbati Aptorum|LYRA (Lyra Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar IBO (Impact BioMedical, Inc.)|TNFA: Qarzning balans kapitallashuviga nisbati|cbdMD Inc. - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati PRFX (PainReform Ltd.)|CYTO - Sof aktivlarga qarzlar|LIPO (Lipella Pharmaceuticals, Inc.) - Balans kapitallashuviga qarzlar|OptiNose Inc (OPTN) - Qarzning balans qiymatiga nisbati|PIRS: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Procaps Group Corp|Petros Pharmaceuticals - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar QLI (qlsyy.net)|SLRN - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati TFF Pharmaceuticals Inc. TFFP